| axapharm ag - Rivaroxaban axapharm vascular 2.5 mg, Filmtabletten | | 69438 | | 01 | | Rivaroxaban axapharm vascular 2.5 mg | | Filmtabletten | | B01AF01 | | Rivaroxaban | | 20.12.2024 | | |
| | Composition | | Filmtablette: rivaroxabanum 2.5 mg, cellulosum microcristallinum, lactosum monohydricum 26.46 mg, natrii laurilsulfas, hypromellosum, carmellosum natricum conexum, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 400, E 172 (flavum), pro compresso obducto corresp. natrium 0.27 mg. | | Packungsbestandteile | | Comprimés filmés | | | | Principe actif | Concentr. | informations additionels |
|---|
| Rivaroxabanum | 2.5 mg | Filmtablette |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | 26.46 mg | | | Macrogol | 400 | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Pro Compresso Obducto | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 56 | DDP | DDP | B | | Non | | 002 | 196 | DDP | DDP | B | | Non |
|
|
